1
|
Pavlović RZ, Finnegan TJ, Metlushko A, Hansen AL, Waudby CA, Wang X, Hoefer N, McComb DW, Pavić A, Plackić N, Novaković J, Bradić J, Jeremić N, Jakovljević V, Šmit B, Matić S, Alvarez-Saavedra MA, Čapo I, Moore CE, Stupp SI, Badjić JD. Dynamic and Assembly Characteristics of Deep-Cavity Basket Acting as a Host for Inclusion Complexation of Mitoxantrone in Biotic and Abiotic Systems. Chemistry 2023; 29:e202303374. [PMID: 37851342 DOI: 10.1002/chem.202303374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2023] [Revised: 10/16/2023] [Accepted: 10/18/2023] [Indexed: 10/19/2023]
Abstract
We describe the preparation, dynamic, assembly characteristics of vase-shaped basket 13- along with its ability to form an inclusion complex with anticancer drug mitoxantrone in abiotic and biotic systems. This novel cavitand has a deep nonpolar pocket consisting of three naphthalimide sides fused to a bicyclic platform at the bottom while carrying polar glycines at the top. The results of 1 H Nuclear Magnetic Resonance (NMR), 1 H NMR Chemical Exchange Saturation Transfer (CEST), Calorimetry, Hybrid Replica Exchange Molecular Dynamics (REMD), and Microcrystal Electron Diffraction (MicroED) measurements are in line with 1 forming dimer [12 ]6- , to be in equilibrium with monomers 1(R) 3- (relaxed) and 1(S) 3- (squeezed). Through simultaneous line-shape analysis of 1 H NMR data, kinetic and thermodynamic parameters characterizing these equilibria were quantified. Basket 1(R) 3- includes anticancer drug mitoxantrone (MTO2+ ) in its pocket to give stable binary complex [MTO⊂1]- (Kd =2.1 μM) that can be precipitated in vitro with UV light or pH as stimuli. Both in vitro and in vivo studies showed that the basket is nontoxic, while at a higher proportion with respect to MTO it reduced its cytotoxicity in vitro. With well-characterized internal dynamics and dimerization, the ability to include mitoxantrone, and biocompatibility, the stage is set to develop sequestering agents from deep-cavity baskets.
Collapse
Affiliation(s)
- Radoslav Z Pavlović
- Department of Chemistry & Biochemistry, The Ohio State University, 1100 W. 18th Avenue, Columbus, OH, 43210, USA
- Department of Chemistry, Northwestern University, Evanston, IL, 60208, USA
- Simpson Querrey Institute for BioNanotechnology, Northwestern University, Chicago, IL, 60611, USA
- Department of Medicine, Northwestern University, Chicago, IL, 60611, USA
- Department of Materials Science and Engineering, Northwestern University, Chicago, IL, 60208, USA
- Department of Biomedical Engineering, Northwestern University, Chicago, IL, 60208, USA)
| | - Tyler J Finnegan
- Department of Chemistry & Biochemistry, The Ohio State University, 1100 W. 18th Avenue, Columbus, OH, 43210, USA
| | - Anna Metlushko
- Department of Chemistry, Northwestern University, Evanston, IL, 60208, USA
- Simpson Querrey Institute for BioNanotechnology, Northwestern University, Chicago, IL, 60611, USA
- Department of Medicine, Northwestern University, Chicago, IL, 60611, USA
- Department of Materials Science and Engineering, Northwestern University, Chicago, IL, 60208, USA
- Department of Biomedical Engineering, Northwestern University, Chicago, IL, 60208, USA)
| | - Alexandar L Hansen
- Campus Chemical Instrument Center, The Ohio State University, Columbus, OH, 43210, USA
| | | | - Xiuze Wang
- Department of Chemistry & Biochemistry, The Ohio State University, 1100 W. 18th Avenue, Columbus, OH, 43210, USA
| | - Nicole Hoefer
- Center for Electron Microscopy and Analysis, The Ohio State University, Columbus, OH, 43210, USA
- Department of Materials Science and Engineering, The Ohio State University, Columbus, OH, 43210, USA
| | - David W McComb
- Center for Electron Microscopy and Analysis, The Ohio State University, Columbus, OH, 43210, USA
- Department of Materials Science and Engineering, The Ohio State University, Columbus, OH, 43210, USA
| | - Aleksandar Pavić
- Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, 11000, Belgrade, Serbia
| | - Nikola Plackić
- Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, 11000, Belgrade, Serbia
| | - Jovana Novaković
- Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
- Center for Excellence for Redox Balance Research in Cardiovascular and Metabolic Disorders, Kragujevac, Serbia
| | - Jovana Bradić
- Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
- Center for Excellence for Redox Balance Research in Cardiovascular and Metabolic Disorders, Kragujevac, Serbia
| | - Nevena Jeremić
- Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
- Center for Excellence for Redox Balance Research in Cardiovascular and Metabolic Disorders, Kragujevac, Serbia
| | - Vladimir Jakovljević
- Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
- Center for Excellence for Redox Balance Research in Cardiovascular and Metabolic Disorders, Kragujevac, Serbia
| | - Biljana Šmit
- University of Kragujevac, Institute for Information Technologies, Department of Science, Kragujevac, Serbia)
| | - Sanja Matić
- University of Kragujevac, Institute for Information Technologies, Department of Science, Kragujevac, Serbia)
| | - Matias A Alvarez-Saavedra
- Department of Chemistry, Northwestern University, Evanston, IL, 60208, USA
- Simpson Querrey Institute for BioNanotechnology, Northwestern University, Chicago, IL, 60611, USA
- Department of Medicine, Northwestern University, Chicago, IL, 60611, USA
- Department of Materials Science and Engineering, Northwestern University, Chicago, IL, 60208, USA
- Department of Biomedical Engineering, Northwestern University, Chicago, IL, 60208, USA)
| | - Ivan Čapo
- Department of Histology and Embryology, Medical Faculty of Novi Sad, Novi Sad, Serbia
| | - Curtis E Moore
- Department of Chemistry & Biochemistry, The Ohio State University, 1100 W. 18th Avenue, Columbus, OH, 43210, USA
| | - Samuel I Stupp
- Department of Chemistry, Northwestern University, Evanston, IL, 60208, USA
- Simpson Querrey Institute for BioNanotechnology, Northwestern University, Chicago, IL, 60611, USA
- Department of Medicine, Northwestern University, Chicago, IL, 60611, USA
- Department of Materials Science and Engineering, Northwestern University, Chicago, IL, 60208, USA
- Department of Biomedical Engineering, Northwestern University, Chicago, IL, 60208, USA)
| | - Jovica D Badjić
- Department of Chemistry & Biochemistry, The Ohio State University, 1100 W. 18th Avenue, Columbus, OH, 43210, USA
| |
Collapse
|
3
|
Pavliuk-Karachevtseva A, Mihalik J, Biel R, Rybárová S, Hodorová I. Chosen Antioxidant Enzymes GPx4 and GPx8 in Human Colorectal Carcinoma: Study of the Slovak Population. Medicina (B Aires) 2022; 58:medicina58020298. [PMID: 35208621 PMCID: PMC8875726 DOI: 10.3390/medicina58020298] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2021] [Revised: 02/08/2022] [Accepted: 02/13/2022] [Indexed: 11/16/2022] Open
Abstract
Background and Objectives: Nowadays colorectal carcinoma (CRC) is one of the most common causes of death in patients with malignant neoplasms worldwide. Our work aimed to determine the possible involvement of glutathione peroxidases 4 and 8 (GPx4 and GPx8) in this specific tumor process. Materials and Methods: The expression of GPx4 and GPx8 in 58 specimens of human colorectal cancer tissues and normal tissues was detected by the indirect immunohistochemical method under a light microscope. Statistical analysis was done by Chi-squared test. Histological findings were compared with data such as gender, age, tumor grade, histotype and lymph nodes alteration. Results: In all specimens of healthy tissue the presence of both, GPx4 and GPx8, was detected in the cytoplasm of epithelial cells. On the other hand, a positive immunohistochemical reaction against GPx4 only in 41.4% and against GPx8 only in 29.3% of human colorectal adenocarcinoma specimens were observed. Any significant difference between the presence of GPx and the age, the gender of the patient, tumor grade, histotype of cancer and the lesion of regional lymph nodes has not been detected. Conclusions: Our foundation could mean, that GPx4 and GPx8 have no important role in CRC pathogenesis, but the loss of these enzymes probably indicates a serious pathological process ongoing in the large intestine. To our knowledge, this is the first paper describing GPx8 presence in human colorectal carcinoma.
Collapse
Affiliation(s)
- Andriana Pavliuk-Karachevtseva
- Department of Anatomy, Medical Faculty, Šafárik University, Šrobárova 2, 041 83 Košice, Slovakia; (A.P.-K.); (J.M.); (S.R.)
| | - Jozef Mihalik
- Department of Anatomy, Medical Faculty, Šafárik University, Šrobárova 2, 041 83 Košice, Slovakia; (A.P.-K.); (J.M.); (S.R.)
| | - Róbert Biel
- Department of Clinical Oncology 2, East-Slovakian Oncological Institute, Rastislavova 43, 041 91 Košice, Slovakia;
| | - Silvia Rybárová
- Department of Anatomy, Medical Faculty, Šafárik University, Šrobárova 2, 041 83 Košice, Slovakia; (A.P.-K.); (J.M.); (S.R.)
| | - Ingrid Hodorová
- Department of Anatomy, Medical Faculty, Šafárik University, Šrobárova 2, 041 83 Košice, Slovakia; (A.P.-K.); (J.M.); (S.R.)
- Correspondence:
| |
Collapse
|
4
|
Tanini D, Carradori S, Capperucci A, Lupori L, Zara S, Ferraroni M, Ghelardini C, Mannelli L, Micheli L, Lucarini E, Carta F, Angeli A, Supuran CT. Chalcogenides-incorporating carbonic anhydrase inhibitors concomitantly reverted oxaliplatin-induced neuropathy and enhanced antiproliferative action. Eur J Med Chem 2021; 225:113793. [PMID: 34507012 DOI: 10.1016/j.ejmech.2021.113793] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2021] [Revised: 08/17/2021] [Accepted: 08/18/2021] [Indexed: 12/12/2022]
Abstract
Platinum-based chemotherapy is widely used for the treatment of different tumors but is associated with serious side effects, among which neuropathic pain. Carbonic anhydrase (CA, EC 4.2.1.1) inhibitors have recently been validated as therapeutic agents in neuropathic pain and as antitumor agents. We report the synthesis of new organochalcogenides bearing the benzensulfonamide moiety acting as potent inhibitors of several human CA isoforms and, in particular, against hCA II and VII endowed with potent neuropathic pain attenuating effects. Moreover, in combination with cisplatin or doxorubicin, some of the new CA inhibitors enhanced the effects of the anticancer drugs capability in counteracting breast cancer MCF7 cell viability. The concomitant anti-neuropathic pain and antiproliferative effects of the new chalcogenide-based CA inhibitors represent an innovative approach for the counteraction and management of side effects associated with clinically platinum drugs as antitumor agents.
Collapse
Affiliation(s)
- Damiano Tanini
- University of Florence, Department of Chemistry "Ugo Schiff", Via Della Lastruccia 3-13, I-50019, Sesto Fiorentino, Italy
| | - Simone Carradori
- Department of Pharmacy, "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy
| | - Antonella Capperucci
- University of Florence, Department of Chemistry "Ugo Schiff", Via Della Lastruccia 3-13, I-50019, Sesto Fiorentino, Italy
| | - Lucrezia Lupori
- University of Florence, Department of Chemistry "Ugo Schiff", Via Della Lastruccia 3-13, I-50019, Sesto Fiorentino, Italy
| | - Susi Zara
- Department of Pharmacy, "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy
| | - Marta Ferraroni
- University of Florence, Department of Chemistry "Ugo Schiff", Via Della Lastruccia 3-13, I-50019, Sesto Fiorentino, Italy
| | - Carla Ghelardini
- Pharmacology and Toxicology Section, Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Firenze, Firenze, Italy
| | - Ldc Mannelli
- Pharmacology and Toxicology Section, Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Firenze, Firenze, Italy
| | - Laura Micheli
- Pharmacology and Toxicology Section, Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Firenze, Firenze, Italy
| | - Elena Lucarini
- Pharmacology and Toxicology Section, Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Firenze, Firenze, Italy
| | - Fabrizio Carta
- NEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, 50019, Sesto Fiorentino, Florence, Italy
| | - Andrea Angeli
- NEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, 50019, Sesto Fiorentino, Florence, Italy; Centre of Advanced Research in Bionanoconjugates and Biopolymers Department, "Petru Poni" Institute of Macromolecular Chemistry, 707410, Iasi, Romania.
| | - Claudiu T Supuran
- NEUROFARBA Department, Sezione di Scienze Farmaceutiche, University of Florence, Via Ugo Schiff 6, 50019, Sesto Fiorentino, Florence, Italy
| |
Collapse
|